» Articles » PMID: 3889247

Involucrin, a Marker of Squamous and Urothelial Differentiation. An Immunohistochemical Study on Its Distribution in Normal and Neoplastic Tissues

Overview
Journal J Pathol
Specialty Pathology
Date 1985 Apr 1
PMID 3889247
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Involucrin is a soluble protein precursor of the cross-linked envelope present in the submembranous zone of human stratum corneum, and subsequently demonstrated in stratified squamous epithelia. The immunoperoxidase technique was used to assess the distribution of involucrin in 107 normal and 318 abnormal tissues. With few exceptions, involucrin was restricted to squamous epithelia, urothelium, some skin appendages and thymic Hassall's corpuscles. In normal squamous epithelium and normal urothelium, staining was most intense in the superficial layers where it was concentrated at the cell periphery and gradually decreased toward the basal layer. This orderly staining pattern was maintained in benign squamous and urothelial lesions and in grade I papillary urothelial carcinomas. Higher grade papillary urothelial carcinomas, infiltrating urothelial and squamous carcinomas, and in situ urothelial and squamous carcinomas demonstrated abnormal staining patterns for involucrin that are described. Foci of squamous differentiation in adenocarcinomas and other epithelial malignancies stained intensely for involucrin. Brenner tumours of the ovary and Walthard rests of the fallopian tube, lesions of uncertain histogenesis but possibly urothelial-related, also stained for involucrin. Results of this study suggest that involucrin is a sensitive and specific marker for squamous and urothelial differentiation, staining patterns for involucrin may be helpful in distinguishing benign from malignant urothelial and squamous lesions, and presence of involucrin may be helpful in determining the histogenesis of selected lesions.

Citing Articles

Pevonedistat Inhibits SOX2 Expression and Sphere Formation but Also Drives the Induction of Terminal Differentiation Markers and Apoptosis within Arsenite-Transformed Urothelial Cells.

Mehus A, Jones M, Trahan M, Kinnunen K, Berwald K, Lindner B Int J Mol Sci. 2023; 24(11).

PMID: 37298099 PMC: 10252886. DOI: 10.3390/ijms24119149.


Post-Aire Medullary Thymic Epithelial Cells and Hassall's Corpuscles as Inducers of Tonic Pro-Inflammatory Microenvironment.

Laan M, Salumets A, Klein A, Reintamm K, Bichele R, Peterson H Front Immunol. 2021; 12:635569.

PMID: 33868260 PMC: 8050345. DOI: 10.3389/fimmu.2021.635569.


Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.

Jin Y, Qin X Biosci Rep. 2020; 40(2).

PMID: 32076707 PMC: 7033310. DOI: 10.1042/BSR20194067.


Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer.

Labrecque M, Coleman I, Brown L, True L, Kollath L, Lakely B J Clin Invest. 2019; 129(10):4492-4505.

PMID: 31361600 PMC: 6763249. DOI: 10.1172/JCI128212.


Loss of H2B monoubiquitination is associated with poor-differentiation and enhanced malignancy of lung adenocarcinoma.

Zhang K, Wang J, Tong T, Wu X, Nelson R, Yuan Y Int J Cancer. 2017; 141(4):766-777.

PMID: 28481029 PMC: 5527746. DOI: 10.1002/ijc.30769.